Skip to main content
Stavros Stavrakis, MD, Cardiology, Oklahoma City, OK

StavrosStavrakisMD

Cardiology Oklahoma City, OK

Cardiac Electrophysiology

Associate Professor, Medicine, University of Oklahoma College of Medicine

Dr. Stavrakis is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Stavrakis' full profile

Already have an account?

  • Office

    825 NE 10th St
    Oklahoma City, OK 73104
    Phone+1 405-271-7001
    Fax+1 405-271-3064

Education & Training

  • University of Oklahoma Health Sciences Center
    University of Oklahoma Health Sciences CenterFellowship, Clinical Cardiac Electrophysiology, 2011 - 2012
  • University of Oklahoma Health Sciences Center
    University of Oklahoma Health Sciences CenterFellowship, Cardiovascular Disease, 2008 - 2011
  • University of Oklahoma Health Sciences Center
    University of Oklahoma Health Sciences CenterResidency, Internal Medicine, 2005 - 2008
  • University of Athens
    University of AthensClass of 2003

Certifications & Licensure

  • OK State Medical License
    OK State Medical License 2007 - 2025
  • American Board of Internal Medicine Cardiovascular Disease
  • American Board of Internal Medicine Clinical Cardiac Electrophysiology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • The Efficacy of Coronary Sinus Reducer in Patients with Refractory Angina—A Systematic Review of the Literature  
    Stavros Stavrakis, MD, Journal of Interventional Cardiology

Authored Content

  • A Potential Relationship Between Gut Microbes and Atrial Fibrillation: Trimethylamine N-oxide, a Gut Microbe-Derived Metabolite, Facilitates the Progression of Atrial FibrillationFebruary 2018

Press Mentions

  • A Ground-Breaking Clinical Trial Using Parasym(TM) Neuromodulation Device Opens Potential New Era of Treatment for Heart Failure
    A Ground-Breaking Clinical Trial Using Parasym(TM) Neuromodulation Device Opens Potential New Era of Treatment for Heart FailureApril 21st, 2022
  • OU Health Doctor Explains Risk of Myocarditis with COVID-19 Vaccine Versus COVID-19 Virus
    OU Health Doctor Explains Risk of Myocarditis with COVID-19 Vaccine Versus COVID-19 VirusSeptember 1st, 2021
  • Smartphone ECG Screening App Aided Detection of AF Among American Indians
    Smartphone ECG Screening App Aided Detection of AF Among American IndiansApril 24th, 2021
  • Join now to see all

Professional Memberships